öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÀîÑÞϼ
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º99

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ººôÎüÄÚ¿Æ
Ñо¿ÁìÓò£º Ö÷ÒªÑо¿copdµÄ·¢²¡»úÖƺÍÖÎÁƺͷΰ©µÄÖÎÁÆ¡£
Ñо¿ÁìÓò£º Ö÷ÒªÑо¿copdµÄ·¢²¡»úÖƺÍÖÎÁƺͷΰ©µÄÖÎÁÆ¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºliyanxia001@163.com


¸öÈ˼òÊö :
ÀîÑÞϼ£¬Å®£¬ºôÎü¶þ¿Æ¸±Ö÷ÈΣ¬2004Äê±ÏÒµÓÚ´óÁ¬Ò½¿Æ´óѧ£¬2013ÄêÓÚÖйúÒ½¿Æ´óѧ¹¥¶Á²©Ê¿Ñ§Î»£¬2016ÄêÓÚÃÀ¹ú¹þ·ð´óѧҽѧԺÂéÊ¡×ÜÒ½Ôº½øÐÞ6¸öÔ¡£´ÓÊÂÁÙ´²¹¤×÷12Ä꣬ÊìÁ·ÕÆÎÕºôÎü¿Æ¼²²¡ÕïÖΣ¬´ÓʺôÎüΣÖØÖ¢¹¤×÷5Ä꣬ÊìÁ·ÕÆÎÕÓд´¡¢ÎÞ´´ºôÎü»úÓ¦Óᢴ²ÅÔÓÒÐÄƯ¸¡µ¼¹ÜµÄ²Ù×÷¼°ºôÎüΣÖØÖ¢µÄ¾ÈÖΣ¬ÊìÁ·ÕÆÎÕÖ§Æø¹Ü¾µ¼ì²éÊõ¡£2015Äê ÁÉÄþºôÎü·Ö»áΣÖØ֢ѧ×é×éÔ±2015Äê ÖйúҽʦЭ»áºôÎü²¡Ñ§·Ö»áÇàÄêίԱ

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿
1¡¢ Ö÷³Ö¿ÎÌ⣺ÐéÄâʵÑé½ÌѧÔÚҽѧ½ÌѧÖеÄÓ¦ÓÃÑо¿£¨JG14DB122£©£¬ÁÉÄþÊ¡½ÌÓý¿Æѧ¡°Ê®¶þÎ塱¹æ»®£¬2014-2016Äê
2¡¢ Ö÷³Ö¿ÎÌ⣺ÁÉÄþÊ¡Ê¡Ö±Ò½Ôº¸Ä¸ïÖصãÁÙ´²¿ÆÊÒÕïÁÆÄÜÁ¦½¨ÉèÏîÄ¿£¨ÇàÄêÏîÄ¿£©ÏîÄ¿Ö÷³ÖÈË¡£ÂýÐÔ×èÈûÐԷμ²²¡¼±ÐÔ¼ÓÖØÆÚ£¨AECOPD£©¼ÒÍ¥ÎÞ´´»úеͨÆøÌåϵ½¨ÉèÓëÍƹãÏîÄ¿£¬2015-2017Äê
´ú±íÎÄÕÂ
1.Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Molecules 2016, 21, 1462 doi:10.3390/molecules**£¨µÚÒ»×÷Õߣ©
2.Synthesis and biological evaluation of azole-diphenylpyrimidine derivatives (AzDPPYs) as potent T790M mutant form of epidermal growth factor receptor inhibitors. Bioorg Med Chem. 2016 Nov 124(21):5505-5512. doi: 10.1016/j.bmc.2016.09.001. Epub 2016 Sep 3.£¨²¢ÁÐͨѶ×÷Õߣ©
3¡¢Jia CF, Li YX, Yang ZQ, et al. Prospective evaluation of unsuspected pulmonary embolism on coronary computed tomographic angiography.J Comput Assist Tomogr. 2012 Mar-Apr36(2):187-90.
4¡¢¡¶·Î˨ÈûµÄÖÎÁÆ¡··¢±íÓÚÖйúʵÓÃÄÚ¿ÆÔÓÖ¾2010Äê.4Ô 30¾íµÚËÄÆÚµÚÒ»×÷Õß
5¡¢¡¶¿¹ÄýÔÚ·Î˨ÈûÖÎÁÆÖеĵØλºÍ·½·¨¡··¢±íÓÚÖйúʵÓÃÍâ¿ÆÔÓÖ¾2010Äê12Ô µÚ12ÆÚµÚÒ»×÷Õß
6¡¢¡¶ÐĵçͼÔÚ¼ø±ð¼±ÐÔ·Î˨ÈûÓë·ÇST¶Î̧¸ßÐͼ±ÐÔ¹ÚÂö×ÛºÏÕ÷ÖеļÛֵ̽ÌÖ¡··¢±íÓÚÖйúÏÖ´úÒ½Ò©ÔÓÖ¾2012Äê14Ô µÚ3ÆÚµÚÒ»×÷Õß
7¡¢±íÏÖΪÃÖÂþÐÔ²¡±äµÄÒþÇò¾ú·ÎÑ×1Àý2012Äê8ÔµÚ17¾íµÚ8ÆÚÁÙ´²·Î¿ÆÔÓÖ¾